According to the FDA prescribing information, injection site reactionsincluding erythema, pruritus (itching), and swellingwere reported in clinical trials
GLP-1 weight loss injections are typically recommended for individuals who: Have a Body Mass Index (BMI) of 30 or higher (obesity) or a BMI of 27 or higher with an obesity-related condition (like type 2 diabetes, hypertension, or high cholesterol), have difficulty losing weight through diet and exercise alone, have type 2 diabetes and need better blood sugar control along with weight management
In February 2026, reports described a crackdown related to copycat weight-loss pills
10.1080/17474124.2023.2172397 22 GuoT.YanW.CuiX.LiuN.WeiX.SunY.et al (2023)
Cortellini A, Leonetti A, Parisi A, Tiseo M, Bordi P, Michiara M, et al